On Pharma's Almanac's Road to 50 States trip, Nick Green, Chief Exceutive Officer at Avid Bioservices, met with Nigel to talk about the company's growth in the last year and why he sees cell and gene therapy as the next big thing in pharma.
On Pharma's Almanac's Road to 50 States trip, Nick Green, Chief Exceutive Officer at Avid Bioservices, met with Nigel to talk about the company's growth in the last year and why he sees cell and gene therapy as the next big thing in pharma.
